MeiraGTx Holdings plc (MGTX) stock
MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3065% below fair value
$8.46−0.28 (-3.20%)
Close on Nov 17, 2026Market cap $812.52MP/E 11.9Yield –
MeiraGTx cash
Cash and short-term investments held at the end of each period.
MeiraGTx's cash was $143.17M at Jun 30, 2026. For fiscal 2025 it was $65.93M, down 37.6% from the year before. The highest annual figure on record is $227.36M in fiscal 2019.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $65.93M | -37.6% |
| FY2024 | Dec 31, 2024 | $105.67M | -19.1% |
| FY2023 | Dec 31, 2023 | $130.65M | +13.1% |
| FY2022 | Dec 31, 2022 | $115.52M | -16.1% |
| FY2021 | Dec 31, 2021 | $137.70M | -34.3% |
| FY2020 | Dec 31, 2020 | $209.52M | -7.8% |
| FY2019 | Dec 31, 2019 | $227.36M | +233.4% |
| FY2018 | Dec 31, 2018 | $68.20M | +686.5% |
| FY2017 | Dec 31, 2017 | $8.67M | -51.6% |
| FY2016 | Dec 31, 2016 | $17.92M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $143.17M | +315.9% |
| Q1 FY2026 | Mar 31, 2026 | $71.54M | +4.3% |
| Q4 FY2025 | Dec 31, 2025 | $65.93M | -37.6% |
| Q3 FY2025 | Sep 30, 2025 | $14.84M | -88.1% |
| Q2 FY2025 | Jun 30, 2025 | $34.42M | -65.9% |
| Q1 FY2025 | Mar 31, 2025 | $68.61M | -43.0% |
| Q4 FY2024 | Dec 31, 2024 | $105.67M | -19.1% |
| Q3 FY2024 | Sep 30, 2024 | $125.03M | +94.1% |
| Q2 FY2024 | Jun 30, 2024 | $101.03M | +8.9% |
| Q1 FY2024 | Mar 31, 2024 | $120.27M | +74.8% |
| Q4 FY2023 | Dec 31, 2023 | $130.65M | +13.1% |
| Q3 FY2023 | Sep 30, 2023 | $64.40M | -43.9% |
| Q2 FY2023 | Jun 30, 2023 | $92.77M | +28.7% |
| Q1 FY2023 | Mar 31, 2023 | $68.78M | -39.5% |
| Q4 FY2022 | Dec 31, 2022 | $115.52M | -16.1% |
| Q3 FY2022 | Sep 30, 2022 | $114.71M | -20.1% |
| Q2 FY2022 | Jun 30, 2022 | $72.11M | -58.2% |
| Q1 FY2022 | Mar 31, 2022 | $113.78M | -42.9% |
| Q4 FY2021 | Dec 31, 2021 | $137.70M | -34.3% |
| Q3 FY2021 | Sep 30, 2021 | $143.63M | -19.9% |
| Q2 FY2021 | Jun 30, 2021 | $172.56M | -11.4% |
| Q1 FY2021 | Mar 31, 2021 | $199.41M | -5.4% |
| Q4 FY2020 | Dec 31, 2020 | $209.52M | -7.8% |
| Q3 FY2020 | Sep 30, 2020 | $179.34M | -29.2% |
| Q2 FY2020 | Jun 30, 2020 | $194.81M | -4.7% |
| Q1 FY2020 | Mar 31, 2020 | $210.79M | -7.3% |
| Q4 FY2019 | Dec 31, 2019 | $227.36M | +233.4% |
| Q3 FY2019 | Sep 30, 2019 | $253.45M | +185.8% |
| Q2 FY2019 | Jun 30, 2019 | $204.40M | +100.0% |
| Q1 FY2019 | Mar 31, 2019 | $227.40M | +600.1% |
| Q4 FY2018 | Dec 31, 2018 | $68.20M | +686.5% |
| Q3 FY2018 | Sep 30, 2018 | $88.68M | +1535.7% |
| Q2 FY2018 | Jun 30, 2018 | $102.18M | +1816.9% |
| Q1 FY2018 | Mar 31, 2018 | $32.48M | +81.2% |
| Q4 FY2017 | Dec 31, 2017 | $8.67M | – |
| Q3 FY2017 | Sep 30, 2017 | $5.42M | – |
| Q2 FY2017 | Jun 30, 2017 | $5.33M | – |
| Q4 FY2016 | Dec 31, 2016 | $17.92M | – |
See a number that looks wrong?